These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17288299)

  • 1. Chronic Myeloid Leukaemia in The 21st Century.
    Frazer R; Irvine AE; McMullin MF
    Ulster Med J; 2007 Jan; 76(1):8-17. PubMed ID: 17288299
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in CML.
    Goldman JM
    Clin Adv Hematol Oncol; 2007 Apr; 5(4):270-2, 292. PubMed ID: 17607286
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic factors influencing feasibility of cytogenetic and molecular analysis in leukapheresis products in chronic myelogenous leukemia patients.
    Carrasco M; Sureda A; Martínez C; Carmona M; Altés A; Martín-Henao GA; Aventín A; Sierra J
    Ann Hematol; 2002 Dec; 81(12):710-6. PubMed ID: 12483367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics of chronic myeloid leukaemia.
    Chase A; Huntly BJ; Cross NC
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):553-71. PubMed ID: 11640869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia.
    Asnafi V; Rubio MT; Delabesse E; Villar E; Davi F; Damaj G; Hirsch I; Dhédin N; Vernant JP; Varet B; Buzyn A; Macintyre E
    Leukemia; 2006 May; 20(5):793-9. PubMed ID: 16541140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC
    Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukaemias into the 21st century. Part 2: the chronic leukaemias.
    Gibson J; Iland HJ; Larsen SR; Brown CM; Joshua DE
    Intern Med J; 2013 May; 43(5):484-94. PubMed ID: 23668266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic myeloid leukemia. State of the art, May 1993].
    Hehlmann R
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):37-43. PubMed ID: 8296189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Tabayashi T; Yamada K; Takeuchi M
    Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse.
    Kim YJ; Kim DW; Lee S; Min CK; Goh HG; Kim SH; Lee JY; Kim YL; Kim HJ; Kim HJ; Lee JW; Kim TG; Min WS; Kim CC
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):718-25. PubMed ID: 15389438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation.
    Gómez M; Urbano-Ispizua A; Cervantes F; Fernández-Avilés F; Rovira M; Carreras E
    Haematologica; 2002 Sep; 87(9):1003-5. PubMed ID: 12217814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukemia.
    Perz JB; Khorashad JS; Marin D; Apperley JF; Olavarria E
    Haematologica; 2006 Aug; 91(8):1145-6. PubMed ID: 16870551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia].
    Tomás JF; Fernández-Rañada JM
    Sangre (Barc); 1998 Apr; 43(2):147-54. PubMed ID: 9656776
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimal residual disease in chronic myeloid leukaemia.
    Cross NC
    Hematol Cell Ther; 1998 Oct; 40(5):224-8. PubMed ID: 9844816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.
    Román J; Alvarez MA; Torres A
    Haematologica; 2000 Oct; 85(10):1072-82. PubMed ID: 11025600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.
    Simon W; Segel GB; Lichtman MA
    Blood Cells Mol Dis; 2006; 37(2):116-24; discussion 125-7. PubMed ID: 16904348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis and therapy in chronic myeloid leukaemia.
    Mehta J; Singhal S; Mehta BC
    J Assoc Physicians India; 1992 Feb; 40(2):130-1. PubMed ID: 1629126
    [No Abstract]   [Full Text] [Related]  

  • 19. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
    Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
    Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment.
    Morris CM
    Methods Mol Biol; 2011; 730():33-61. PubMed ID: 21431633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.